Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long ‐Term Normalization of Systemic Sclerosis Molecular Signatures

ConclusionParalleling the observed clinical benefit, HSCT leads to durable long-term normalization of the molecular signature in SSc, with completion of immune resetting to 54 months after HSCT.

Source: Arthritis and Rheumatology - April 30, 2024 Category: Rheumatology Authors: Nancy Wareing, Xuan Wang, Lynette Keyes ‐Elstein, Ellen A. Goldmuntz, Marka A. Lyons, Peter McSweeney, Daniel E. Furst, Richard A. Nash, Leslie J. Crofford, Beverly Welch, Ashley Pinckney, Maureen D. Mayes, Keith M. Sullivan, Shervin Assass Tags: Brief Report Source Type: research